Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $2.67 in the prior trading day, Solid Biosciences Inc (NASDAQ: SLDB) closed at $2.70, up 1.12%. In other words, the price has increased by $1.12 from its previous closing price. On the day, 0.57 million shares were traded. SLDB stock price reached its highest trading level at $2.79 during the session, while it also had its lowest trading level at $2.6.
Ratios:
Our goal is to gain a better understanding of SLDB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.20 and its Current Ratio is at 5.20. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on January 08, 2025, initiated with a Buy rating and assigned the stock a target price of $16.
On December 13, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $16.
On December 10, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $15.JMP Securities initiated its Mkt Outperform rating on December 10, 2024, with a $15 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 11 ’25 when Kahn Clare bought 1,860 shares for $5.34 per share. The transaction valued at 9,924 led to the insider holds 2,960 shares of the business.
Bain Capital Life Sciences Inv bought 1,000,000 shares of SLDB for $4,030,000 on Feb 19 ’25. The 10% Owner now owns 5,034,582 shares after completing the transaction at $4.03 per share. On Feb 19 ’25, another insider, PERCEPTIVE ADVISORS LLC, who serves as the Director of the company, bought 5,000,000 shares for $4.03 each. As a result, the insider paid 20,150,000 and bolstered with 11,833,539 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLDB now has a Market Capitalization of 209231104 and an Enterprise Value of 84487992.
Stock Price History:
The Beta on a monthly basis for SLDB is 2.38, which has changed by -0.73 over the last 52 weeks, in comparison to a change of 0.059571505 over the same period for the S&P500. Over the past 52 weeks, SLDB has reached a high of $11.28, while it has fallen to a 52-week low of $2.47. The 50-Day Moving Average of the stock is -38.29%, while the 200-Day Moving Average is calculated to be -53.92%.
Shares Statistics:
The stock has traded on average 2.47M shares per day over the past 3-months and 1353230 shares per day over the last 10 days, according to various share statistics. A total of 77.49M shares are outstanding, with a floating share count of 67.09M. Insiders hold about 13.42% of the company’s shares, while institutions hold 54.14% stake in the company. Shares short for SLDB as of 1743379200 were 8620590 with a Short Ratio of 3.49, compared to 1740700800 on 7319778. Therefore, it implies a Short% of Shares Outstanding of 8620590 and a Short% of Float of 13.239999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
